Longeveron Inc
Change company Symbol lookup
Select an option...
LGVN Longeveron Inc
GSIT GSI Technology Inc
GME GameStop Corp
CMBM Cambium Networks Corp
S SentinelOne Inc
BAC Bank of America Corp
SDA SunCar Technology Group Inc
RAIN Rain Oncology Inc
EOI Eaton Vance Enhanced Equity Income Fund
OLNCF Omni Lite Industries Canada Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Longeveron Inc. is a clinical-stage biotechnology company, which is developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, such as aging related frailty, Alzheimer's disease (AD), acute respiratory distress syndrome (ARDS), and hypoplastic left heart syndrome (HLHS). Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.

Price
Delayed
$3.22
Day's Change
0.06 (1.90%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.30
Day's Low
3.21
Volume
(Light)

Today's volume of 5,693 shares is on pace to be much lighter than LGVN's 10-day average volume of 22,590 shares.

5,693

Upcoming Events

LGVN's fiscal year ends in December
There are no upcoming events for LGVN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
May 12, 2023Q1 2023 Earnings Release-$0.22-$0.23 to -$0.19-$0.17
March 10, 2023Q4 2022 Earnings Release-$0.21-$0.25 to -$0.10-$0.20
November 14, 2022Q3 2022 Earnings Release-$0.25-$0.24 to -$0.20--
August 12, 2022Q2 2022 Earnings Release-$0.27-$0.26 to -$0.19--

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.